Signos

Signos Competitive Intelligence & Landscape

signos.com ·

Signos
ForesightIQ Predictions

What is Signos likely to do next?

ForesightIQ connects Signos's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.

Hiring signal

Senior hiring patterns point to a planned enterprise product line launching within two quarters.

High confidence · Next 1–2 quarters
Product signal

Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.

Likely · Next quarter
Market signal

Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.

Plausible · Next 2–3 quarters
Signos Unlock Signos's predicted moves

Free · generated in ~60 seconds · no signup to preview

Overview

Signos Overview

Signos (signos.com) is a metabolic health company dedicated to helping individuals achieve their weight goals through continuous glucose monitoring (CGM) and AI-powered insights. The company utilizes a person's unique metabolic signals, specifically glucose levels, to provide personalized recommendations for diet and exercise. Their core service is an all-in-one membership that includes CGM hardware, metabolic insights, guidance from registered dietitians, and actionable prompts related to meals, movement, and sleep, aiming to simplify the weight management process [signos.com]. Signos emphasizes a data-driven approach, transforming personal metabolic data into actionable insights that empower users to make informed choices and achieve sustainable progress [signos.com/about].

Signos launched out of stealth mode in November 2021 with $17 million in funding and a waitlist of over 100,000 individuals [signos.com/blog/signos-launch]. The company's mission is to optimize metabolic health for all, addressing the significant percentage of the American population considered overweight, obese, or metabolically

Competitors

Signos Competitors

Signos (signos.com) operates in the competitive continuous glucose monitoring (CGM) space, specifically targeting weight management. One of its primary direct competitors is Levels, a health and wellness company that also utilizes CGM technology for metabolic health. Levels provides a subscription-based service offering health monitoring, clinician-reviewed insights, and personalized recommendations, akin to Signos. While both offer CGM programs, Signos distinguishes itself by explicitly focusing on weight loss, whereas Levels offers a broader approach to metabolic health management [https://www.signos.com/signos-vs-levels].

Nutrisense is another significant competitor in the CGM market, often compared directly with Signos and Levels [https://www.mindbodygreen.com/articles/signos-vs-nutrisense-vs-levels]. Like Signos, Nutrisense leverages CGM data to help users understand their metabolic responses to various factors. However, the exact differences in their coaching methodologies, pricing structures, and overall user experience contribute to their unique market positioning, with Signos emphasizing its specific design for sustainable weight loss.

Stelo by Dexcom is a direct competitor, as Signos itself compares its offerings to Stelo [https://www.signos.com/signos-vs-all].

Dexcom is a major player in the medical device industry, known for its glucose monitoring technology.

Stelo by Dexcom offers a CGM device that, according to Signos, is the same sensor type used by Signos [https://optimizebiomarkers.com/cgm-compare/signos-vs-dexcom-stelo]. The primary differentiation often lies in the accompanying software, personalized insights, and support services that each company builds around the core CGM technology.

Stelo by Dexcom is positioned as a reliable CGM solution, but Signos aims to add value through its integrated weight management program.

Finally, Lingo by Abbott also stands as a notable competitor in the CGM space for metabolic health.

Abbott is another established medical device manufacturer, and Lingo represents their entry into the direct-to-consumer metabolic health market, similar to Stelo by Dexcom.

Signos directly compares itself to Lingo, highlighting its unique advantages in combining hardware with a comprehensive weight loss program, whereas Lingo focuses on general metabolic insights through its CGM technology [https://www.signos.com/signos-vs-all].

Alternatives

Signos Alternatives

Product & Pricing

Signos Product and Pricing Intelligence

Signos (signos.com) offers a comprehensive Continuous Glucose Monitoring (CGM) system designed for weight management, distinguishing itself through its integrated approach. The platform provides real-time glucose insights, personalized dietary recommendations, and AI-driven nudges to help users stabilize blood sugar and achieve weight goals. Unlike piecing together various tools, Signos consolidates hardware (CGMs), a dedicated app, and expert support into a single membership. The company emphasizes understanding how food, movement, sleep, and daily habits impact glucose levels to facilitate sustainable progress. Its program includes real-time blood sugar trends, a personalized blood sugar target, and in-app nutritionist support [wf.signos.com/how-it-works].Signos provides a single-app experience, pairing its services with next-generation continuous glucose monitors, and is noted as a venture-backed partner of Dexcom, a leader in glucose monitoring [wf.signos.com/how-it-works].

Signos offers a Weight Transformation Kit to help users hit their weight goals, discover

Leadership

Signos Management and Leadership Team

Signos (signos.com) is led by a dedicated executive team focused on leveraging continuous glucose monitoring (CGM) for weight management. The company's vision is spearheaded by Sharam Fouladgar-Mercer, who serves as both Founder & CEO. He emphasizes the company's mission to provide personalized metabolic insights, stating, "We provide visibility into everybody’s unique metabolic needs... we can work with people to turn diets that don’t work into plans that do" [signos.com/blog/signos-launch]. Co-founder Bill Tancer holds the role of Chief of Data Science and is also a New York Times best-selling author, creator, and host of Signos’ podcast, "Body Signals" [wf.signos.com/blog-authors/bill-tancer].

The executive leadership at Signos also includes Roger Neel as Chief Technology Officer & CMO, Dan Gusz as Chief of Staff, and Pierre Wehbe as Co-Founder & Chief Architect [signos.com/about]. In a notable update, Hannah Russin has been identified as the Chief Marketing Officer (CMO), joining Bill Tancer on the "Body Signals" podcast to discuss eating experimentation and results [signos.com/blog/give-me-back-my-carbs-with-resistant-starch]. This indicates a shift in the CMO role previously listed as Roger Neel.

Further bolstering the leadership team are Emma Allison as VP, Product, Colin Rogers as VP, Healthcare, and Lindsay Peterson as VP Finance & Operations [signos.com/about]. The company's commitment to growth and expanding its core team was highlighted in October 2023 when Signos announced $20 million in Series B funding, aimed at addressing obesity and metabolic health challenges [signos.com/blog/signos-announces-series-b-funding]. The team also features a diverse group of health and fitness writers, including a medical doctor and certified health coaches, contributing to their blog [wf.signos.com/blog-authors/signos-team-author].

Financials

Signos Financial Performance, Fundraising, M&A

Signos, a leading metabolic health platform found at signos.com, has demonstrated significant financial growth and investor confidence since its inception. The company launched from stealth mode in October 2021 with an impressive $17 million in funding, already boasting a waitlist of over 100,000 individuals eager to utilize its AI-powered continuous glucose monitoring (CGM) for weight management. This initial funding underscored the market's demand for data-driven, personalized health solutions.

Further solidifying its financial position, Signos announced a Series B funding round of $20 million in October 2023. This capital injection was specifically aimed at expanding access to its metabolic health and weight loss platform, directly addressing the growing challenges of obesity. The company is notably venture-backed by major players in technology and healthcare, including Google, Dexcom, and Samsung, highlighting strong strategic partnerships and investor belief in its innovative approach to metabolic weight management for both individuals and enterprise employers.

While specific overall revenue figures are not publicly disclosed, Signos operates on a membership model, offering its comprehensive service for $127 per month. This single membership includes hardware, registered dietitian support, metabolic insights, and actionable prompts, differentiating it from a DIY approach that could cost upwards of $800 per month when piecing together continuous glucose monitors, smart rings or watches, and dietitian consultations. This transparent pricing structure and integrated offering position Signos as a competitive and value-driven solution in the health and wellness market.

Partnerships

Signos Partnerships, Clients and Vendors

Signos (signos.com) engages with a diverse range of partners, clients, and vendors to deliver its AI-powered continuous glucose monitoring (CGM) for weight management. The company offers solutions for Health Partners (functional medicine, longevity, and coaching protocols), Employers, and Health Plans [signos.com/organizations/request-demo]. Notable partnerships include collaborations with OpenLoop Clinical and Pharmaceutical Services for clinical and pharmaceutical needs [signos.com/organizations/partners], and a significant alliance with Nourish for dietitian support [support.signos.com/hc/en-us/articles/19806398696724-How-do-I-get-support-from-a-dietitian-through-the-Signos-and-Nourish-Partnership].

For enterprise clients, Signos is venture-backed by prominent names like Google, Dexcom, and Samsung, showcasing strong industry support [signos.com/organizations/employers]. The platform is specifically designed to redefine metabolic weight management for enterprise employers, serving as a "first-line defense against escalating specialty drug costs" [signos.com/organizations/employers].

Signos has partnered with various employers to offer its program as a sponsored benefit, examples include clients promoted through unique codes such as "MESAWELLNESS360" and "3RiversQ126" [enterprise.signos.com] [enterprise.signos.com/pages/3rivers]. These employer partnerships emphasize helping employees achieve smarter weight management and better health through glucose stabilization.

In terms of technology integrations and ecosystem relationships, Signos leverages the world-leading Dexcom technology for its continuous glucose monitors, providing a single-app experience [wf.signos.com/how-it-works]. The Signos platform integrates with major health platforms, including Apple Health for iOS devices and Google Health Connect for Android devices [support.signos.com/hc/en-us/articles/15421416608532-How-do-you-connect-an-external-device-or-app-with-Signos-supported-integrations] [support.signos.com/hc/en-us/articles/46028595373588-How-do-I-integrate-Signos-with-3rd-party-apps-devices-Android]. These integrations allow Signos to automatically sync and import a comprehensive range of health data, including exercise, sleep, weight, body fat, and heart rate, from various third-party devices and apps [support.signos.com/hc/en-us/articles/15421416608532-How-do-you-connect-an-external-device-or-app-with-Signos-supported-integrations].

Events

Signos Event Participations

Signos actively engages its audience through various online events, primarily focusing on educational Body Signals Live series. These webinars feature Signos's nutrition experts, such as Registered Dietitian Alyssa Wilson, Head of Nutrition, who provides valuable insights into metabolic health and weight management. Topics covered include understanding the link between glucose, anxiety, and mental health, and practical advice on integrating colorful, non-starchy vegetables and whole grains into meals, as demonstrated in "Elevate Your Plate - A Special Body Signals Live Recording" [signos.com/blog/elevate-your-plate].

The company also hosts discussions with key personnel like CMO Hannah Russin, who, alongside host Bill Tancer, explores specialized nutritional topics such as resistant starches and their incorporation into diets [wf.signos.com/blog/cgm-data-weight-loss]. These events serve as a platform for Signos to share its expertise and demonstrate how its AI-powered platform, combined with Continuous Glucose Monitoring (CGM), offers personalized, science-backed guidance for health and weight management [signos.com/blog/lst-study].

While specific details about large-scale conferences or trade shows are not prominently featured, Signos maintains a strong digital presence through its blog, where it regularly publishes articles on metabolic health, nutrition, and weight loss [signos.com/blog/].

Signos also encourages engagement through its "Contact Us" page for press/media inquiries and general inquiries [signos.com/contact-us], and offers demo requests for organizations [signos.com/organizations/request-demo], indicating its outreach to enterprise clients and potential partners. The company also actively encourages users to sign up for newsletters to stay informed about special offers and exciting Signos news [signos.com/contact-us].

Frequently Asked Questions

What does Signos's recent Series B funding imply about its market strategy?

Signos's $20 million Series B funding in October 2023, backed by Google, Dexcom, and Samsung, indicates a strategic focus on expanding access to its metabolic health and weight loss platform, particularly to address the growing challenges of obesity. The investment aims to solidify its position in the market for both individual consumers and enterprise employers.

What does Signos's membership pricing model reveal about its competitive positioning?

Signos's membership model, priced at $127 per month, bundles CGM hardware, registered dietitian support, metabolic insights, and actionable prompts. This integrated offering positions Signos as a value-driven alternative to the DIY approach of sourcing separate components, which could cost upwards of $800 monthly, differentiating it from competitors that may unbundle these services.

What does Signos's C-suite update, specifically regarding the CMO role, signal?

The shift in the CMO role from Roger Neel to Hannah Russin, who now co-hosts the 'Body Signals' podcast, suggests an intensified focus on content-driven marketing and direct engagement with health and nutrition topics. This move likely aims to leverage thought leadership and educational content to expand Signos's brand presence and attract new users.

How do Signos's partnerships, particularly with Nourish and OpenLoop, indicate its strategic direction?

Signos's partnerships with Nourish for dietitian support and OpenLoop Clinical and Pharmaceutical Services suggest a strategy to provide comprehensive, integrated health solutions beyond just CGM data. These alliances allow Signos to offer robust clinical and nutritional guidance, enhancing its value proposition for personalized weight management.

What do Signos's enterprise client partnerships, like those with 'MESAWELLNESS360' and '3RiversQ126', signify?

Signos's partnerships with employers, promoted through unique codes such as 'MESAWELLNESS360' and '3RiversQ126', indicate a strategic expansion into the corporate wellness market. This move positions Signos as a 'first-line defense against escalating specialty drug costs' for employers, aiming to provide sponsored metabolic weight management benefits to employees.

What does Signos's reliance on Dexcom technology suggest about its product strategy?

Signos's reliance on world-leading Dexcom technology for its continuous glucose monitors, while offering a single-app experience, suggests a product strategy focused on leveraging established, reliable hardware. This allows Signos to differentiate itself through its AI-powered insights, personalized recommendations, and comprehensive weight management program rather than developing proprietary CGM hardware.

How does Signos's specific focus on weight loss differentiate it from competitors like Levels and Nutrisense?

Signos explicitly targets weight loss as its primary focus, unlike Levels, which offers a broader approach to metabolic health, or Nutrisense, which emphasizes comprehensive metabolic insights with dietitian coaching. This specialized focus allows Signos to tailor its AI-powered insights and recommendations specifically for sustainable weight management, aiming for a distinct market segment.

What do Signos's integrations with Apple Health and Google Health Connect imply about its user experience strategy?

Signos's integrations with Apple Health and Google Health Connect demonstrate a strategy to offer a seamless and comprehensive user experience. By automatically syncing data such as exercise, sleep, weight, body fat, and heart rate from various third-party devices, Signos aims to provide a holistic view of a user's health, enhancing its personalized metabolic insights.

What is the strategic value of Signos's 'Body Signals Live' webinar series?

Signos's 'Body Signals Live' webinar series serves as a strategic platform for audience engagement and expert positioning. By featuring its nutrition experts and CMO to discuss metabolic health and weight management, Signos educates potential users, reinforces its science-backed approach, and demonstrates how its platform provides personalized guidance.

What does the shift in leadership for the CMO role from Roger Neel to Hannah Russin signify about Signos's marketing direction?

The leadership change with Hannah Russin becoming CMO, actively participating in the 'Body Signals' podcast alongside Bill Tancer, suggests a strategic pivot towards thought leadership and content-driven marketing. This move indicates a focus on deep dives into nutritional science and user education, likely to strengthen Signos's brand authority and engage potential customers through informational content.

How does Signos's offering compare in value against alternatives like Nutrisense and Levels, particularly on pricing and features?

Signos offers an FDA-cleared, HSA/FSA eligible membership at $129/month, including two CGM sensors monthly and in-app nutritionist support, specifically targeting weight loss. This positions it distinctively against Nutrisense, which includes dietitian coaching as standard for $149/month, and Levels, which charges $24/month for its app but requires separate purchase of sensors, catering to users who prefer sourcing their own hardware and a self-directed biohacking approach.

Powered by ForesightIQ · Competitive intelligence from digital exhaust